Advanced IVF Services
Blastocyst Culture
Blastocyst culture involves extending the in-vitro fertilization (IVF) embryo culture in the laboratory for five to six days, allowing embryos to develop into a more advanced stage called a blastocyst. This extended culture period enables us to select the most robust and viable embryos for transfer, significantly improving implantation rates and pregnancy success, while also reducing the risk of multiple pregnancies.
Endometrial Receptivity Array (ERA)
The Endometrial Receptivity Array (ERA) is a sophisticated diagnostic test that analyzes the receptivity of the uterine lining (endometrium) to embryo implantation. By identifying the precise optimal "window of implantation" for each individual woman, ERA helps personalize the timing of embryo transfer. This is particularly beneficial for patients who have experienced recurrent implantation failure, greatly increasing their chances of a successful pregnancy.
Pre-implantation Genetic Testing (PGT)
PGT involves genetically testing embryos before they are transferred during an IVF cycle. There are different types: PGT-A screens for chromosomal abnormalities, PGT-M identifies specific gene defects, and PGT-SR detects structural chromosomal rearrangements. This testing helps select healthy embryos, significantly reducing the risk of miscarriage, failed implantation, and preventing the inheritance of genetic diseases, thereby leading to higher success rates in IVF.
Assisted Hatching (AH)
Assisted Hatching is a delicate micro-procedure performed on embryos just before transfer. A tiny opening is made in the embryo's outer shell, known as the zona pellucida. This helps the embryo "hatch" more easily from its shell and successfully implant into the uterine lining. It is often recommended for older women, embryos with a thick zona, or patients who have experienced previous implantation failures in IVF cycles.
Ovarian PRP For Low AMH
Ovarian Platelet-Rich Plasma (PRP) therapy is an innovative treatment where a concentrated solution of a woman's own platelets is injected into the ovaries. The growth factors in PRP are believed to rejuvenate ovarian function, potentially improving ovarian reserve, and increasing the number and quality of eggs retrieved. This therapy offers new hope for women with low AMH (Anti-Müllerian Hormone) levels or those experiencing premature ovarian insufficiency.
Endometrial PRP For Thin Endometrium
Endometrial Platelet-Rich Plasma (PRP) therapy involves infusing a concentrated solution of a woman's own platelets directly into the uterine lining. This therapy is specifically designed to improve the thickness and receptivity of a thin endometrium, which can often be a significant barrier to successful embryo implantation. By promoting tissue regeneration, Endometrial PRP enhances the chances of a successful pregnancy in IVF cycles.
Stem Cell Therapy
Stem cell therapy is an advanced and largely experimental treatment that involves using specialized stem cells to potentially regenerate or repair damaged reproductive tissues. While still in its developmental stages for fertility applications, it holds significant promise for challenging conditions such as premature ovarian failure, very thin endometrium unresponsive to conventional treatments, or severe forms of male factor infertility, aiming to restore and improve reproductive function.